Saturday 10 October 2026 Export all MODD data to Excel Powerpack

Modular Medical, Inc.

MODD Healthcare Medical Devices

In the quarter to June 2026, EPS grew 67.0% and free cash flow fell 5.61%, each against the same quarter a year earlier.

2.72 0.06 +2.26%
Market cap
$25.3M
P/E
0.0×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

Insider Decisions trades per month

Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — — — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 25.26
Revenue —
Net Income (28.03)
Free Cash Flow (28.04)
Net Debt (3.92)
Current Ratio 3.25 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 0.00
Fwd P/E —
P/S ratio 0.00
P/B ratio 1.38
Past 5Y EPS Growth —
This Y EPS Growth 38.46% (at or above 15%: strong)
Next Y EPS Growth 18.75% (at or above 15%: strong)
Next Y revenue growth —
Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/B against its own 10 years 5.74%
10-year low 10-year high

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities $m

2024 2025 2026 Q'26
Cash 9 13 7 4
Receivables — — — —
Inventory — — — —
Other — — — —
10 14 8 5
2024 2025 2026 Q'26
Payables 1 0 1 1
ST’ Debt — — — —
Other — — — —
1 1 2 1

Compound Annual Growth %

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 36.67%

Revenue $m

Year
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Jun Sep Dec Mar Year
’26 (6) — — — —
’26 (5) (5) (7) (6) (24)
’25 (4) (4) (4) (4) (16)
’24 (3) (3) (4) (4) (14)
’23 (3) (3) (3) (3) (11)
’22 (2) (3) (2) (3) (10)
’21 (2) (2) (2) (1) (6)
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Jun Sep Dec Mar Year
’26 (7) — — — —
’26 (6) (6) (8) (7) (28)
’25 (4) (4) (5) (5) (18)
’24 (4) (4) (4) (4) (16)
’23 (3) (3) (3) (4) (13)
’22 (2) (3) (2) (3) (10)
’21 (2) (2) (2) (1) (6)
Fiscal quarters ending in the months shown.

EPS $

Jun Sep Dec Mar Year
’26 (1.19) — — — —
’26 (3.60) (4.20) (3.30) (1.10) (12.36)
’25 (3.60) (4.20) (3.90) (3.60) (15.31)
’24 (6.61) (5.71) (6.91) (4.20) (23.42)
’23 (9.91) (9.61) (9.31) (9.91) (38.44)
’22 (22.98) (20.81) (22.82) (15.62) (82.28)
’21 (3.00) (3.00) (8.99) (3.00) (35.67)
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance

Group Line 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 Trend 2027e 2028e 2029e
Price, $
Price, $ Low 24.30 18.00 18.00 21.60 162.00 47.10 25.20 32.40 8.40 1.72

Analyst estimates 2027–2029

Powerpack
High 24.30 24.30 21.60 342.00 585.00 450.00 115.20 79.50 44.67 16.20
People
People Employees — — 6 13 20 25 38 40 54 51
Revenue/emp, $m — — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income, $m
Income, $m Revenue — — — — — — — — — —
Gross margin, % — 0.00 0.00 0.00 0.00 0.00 0.00 — — —
EBT — (1) (3) (5) (7) (19) (14) (17) (19) (28)
EBT margin, % — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net income — (1) (3) (5) (7) (19) (14) (17) (19) (28)
Depreciation — 0 0 0 0 2 0 0 1 2
Per share, $
Per share, $ Revenue — 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings — (1.48) (4.60) (9.01) (35.67) (82.28) (38.44) (23.42) (15.31) (12.36)
Cash flow — (1.78) (3.27) (6.88) (28.57) (45.26) (27.32) (18.72) (12.75) (10.40)
Capex — (0.03) (0.14) (0.44) (0.53) (0.24) (4.06) (2.28) (2.02) (1.72)
Free cash flow — (1.82) (3.41) (7.32) (29.10) (45.50) (31.39) (21.00) (14.77) (12.12)
Book value — 9.73 11.72 4.84 (6.17) 38.98 12.60 15.48 13.85 5.67
Shares, m — 0 1 1 0 0 0 1 1 2
Valuation, ×
Valuation, × P/E — — — — — — — — — —
P/S — — — — — — — — — —
P/B — — — — — — — — — —
EV/Sales — — — — — — — — — —
EV/FCF — — — — — — — — — —
Cash, $m
Cash, $m Operating cash flow — (1) (2) (4) (6) (10) (11) (14) (16) (24)
Capex — 0 0 0 0 0 (2) (2) (2) (4)
Free cash flow — (1) (2) (4) (6) (10) (13) (16) (18) (28)
Balance, $m
Balance, $m Working capital — 4 6 3 (2) 8 3 8 12 6
Total debt — — — 0 3 0 2 — — —
Net debt — (4) (7) (3) (1) (9) (4) (9) (13) (7)
Shareholders’ equity — 4 6 3 (1) 9 5 12 17 13
Returns, %
Returns, % ROA — (12.00) (46.23) (101.24) (241.63) (308.12) (162.41) (165.97) (115.69) (168.27)
ROIC — (1,867.15) 0.00 0.00 0.00 0.00 (679.23) (475.71) (298.97) (286.27)
ROE — (31.96) (47.06) (113.79) (920.35) (492.82) (199.51) (210.34) (131.58) (188.05)
Negative figures in brackets.

All 10 years →

Charts ten years each

Modular Medical, Inc. vs peers in Medical Devices (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
NSYS Nortech Systems Incorporated $32.2M 30.7× 17.5× +9.34% (above 0%: growing) −8.33% (below 0%: shrinking) −1,567.16% (below 0%: shrinking) 17.00% 1.86% Compare
ITOC iTonic Holdings Ltd. $29.4M — — — — — — — Compare
ARAY Accuray Incorporated $28.8M — (loss-making) — (loss-making) −20.87% (below 0%: shrinking) n/m +117.83% (above 0%: growing) 35.22% 5.47% Compare
BDMD Baird Medical Investment Holdings Limited $25.3M — (loss-making) — — n/m −598.12% (below 0%: shrinking) — — Compare
MODD Modular Medical, Inc. $25.3M — (loss-making) — — n/m −5.61% (below 0%: shrinking) 0.00% 0.00%
PMI Flag Ship Acquisition Corp $22.6M 0.3× — (loss-making) +38.62% (above 0%: growing) n/m +46.79% (above 0%: growing) 20.85% (156.70%) Compare
NSPR InspireMD, Inc. $22.3M — (loss-making) — (loss-making) −0.39% (below 0%: shrinking) n/m −26.00% (below 0%: shrinking) (43.70%) (815.64%) Compare
PAVM PAVmed Inc. $21.5M — (loss-making) — (loss-making) +450.00% (above 0%: growing) n/m −125.63% (below 0%: shrinking) (269.70%) (21,278.79%) Compare
LFWD Lifeward Ltd. $18.2M — (loss-making) — (loss-making) +15.71% (above 0%: growing) n/m −52.77% (below 0%: shrinking) 40.90% (62.69%) Compare
Median of peers $24.0M — — +12.53% — −52.77% 18.93% (109.69%)

All 149 Medical Devices stocks →

Modular Medical, Inc. (MODD) key facts

  • Modular Medical, Inc. (MODD) is a Medical Devices company in the Healthcare sector, listed on Nasdaq.
  • As of October 9, 2026, MODD traded at $2.72, a market capitalization of $25.3 million.
  • Return on equity was −188.1% and debt-to-equity 0.00.

Source: company filings (standardised) and stockrow calculations.

Modular Medical, Inc. (MODD) Latest News

No news at this impact. Lower the threshold for more.

stockrow.com/MODD · For information only; not investment advice. · © 2026 stockrow.com